Hepatocellular carcinoma is one of the leading causes of cancer-related death worldwide. Recently, radiomics and radiogenomics have been introduced as novel dimensions in oncology research. In the current review, we summarize the clinical applications of radiomics and radiogenomics in hepatocellular carcinoma.